Patents Assigned to The Washington University
-
Patent number: 12247909Abstract: A method of transmitting at least one optical signal through an add-drop filter includes directing the at least one optical signal into a first tapered optical fiber of the add-drop filter. The add-drop filter includes an active resonator side-coupled between the first tapered optical fiber and a second tapered optical fiber, and the active resonator is doped with at least one rare earth ion. A tuned optical gain is produced by delivering a tuned amount of pump laser energy to the at least one rare earth ion at a sub-lasing level, the tuned optical gain configured to compensate an intrinsic loss of the active resonator.Type: GrantFiled: May 23, 2023Date of Patent: March 11, 2025Assignee: Washington UniversityInventors: Sahin Kaya Ozdemir, Lan Yang, Bo Peng, Faraz Monifi
-
Patent number: 12246114Abstract: A three-dimensional electrospun nanofiber scaffold for use in repairing a defect in a tissue substrate is provided. The three-dimensional electrospun nanofiber scaffold includes a first layer formed by a first plurality of electrospun polymeric fibers and a second layer formed by a second plurality of electrospun polymeric fibers. The second layer is coupled to the first layer using a coupling process and includes a plurality of varying densities formed by the second plurality of electrospun polymeric fibers. The first and second layers are configured to degrade via hydrolysis after at least one of a predetermined time or an environmental condition. The three-dimensional electrospun nanofiber scaffold is configured to be applied to the tissue substrate containing the defect.Type: GrantFiled: May 12, 2020Date of Patent: March 11, 2025Assignee: Washington UniversityInventor: Matthew R. MacEwan
-
Patent number: 12247196Abstract: The present disclosure provides for engineered microorganisms and methods of making and using same. The engineered microorganisms as described herein can have a surface display and can be useful as therapeutic agents (e.g., sponges) and biosensors.Type: GrantFiled: September 20, 2019Date of Patent: March 11, 2025Assignee: Washington UniversityInventors: Gautam Dantas, Suryang Kwak, Herbert Virgin
-
Patent number: 12247246Abstract: The present invention provides compounds useful as inhibitors of TIR NADase activity, compositions thereof, and methods of using the same. The present invention is useful for inhibition of TIR-domain NADase activity and/or treating microbial infection and/or modulating microbial physiology.Type: GrantFiled: November 29, 2022Date of Patent: March 11, 2025Assignee: Washington UniversityInventors: Jeffrey D. Milbrandt, Aaron DiAntonio, Kow Essuman, Xianrong Mao, Yo Sasaki, Dan Summers
-
Publication number: 20250075277Abstract: Among the various aspects of the present disclosure is the provision of a ddPCR-based method of detecting oncogenic fusions, and its use in screening and monitoring a cancer treatment is disclosed. A method for detecting oncogenic fusions involving the histone-lysine N-methyltransferase 2A (KMT2A) gene is described.Type: ApplicationFiled: August 28, 2024Publication date: March 6, 2025Applicant: Washington UniversityInventors: Andrew Young, Hannah Davis, Grant Challen
-
Publication number: 20250075041Abstract: Compositions of saltwater-stable adhesive hydrogels are provided, as well as methods of use thereof in adhesion, drug delivery, antibiotic delivery, surface coating, and antifouling applications. Disclosed copolymer complexes exhibit reversible ionic strength-based solubility between a soluble complex and an insoluble hydrogel, and include a first polynorbornene (PNB)-based bottlebrush copolymer including a plurality of ?-cyclodextrin (?-CD)-terminated oligoethylene glycol sidechains and a second PNB-based bottlebrush copolymer including a plurality of positively charged adamantane (Ad)-terminated oligoviologen sidechains. In some embodiments, the second PNB-based bottlebrush copolymer further includes at least one porphyrin-terminated sidechain and/or has at least one electrostatically loaded, negatively charged therapeutic drug.Type: ApplicationFiled: August 30, 2024Publication date: March 6, 2025Applicant: Washington UniversityInventors: Jonathan Barnes, Yipei Zhang, Ruihan Li, Tarryn Trick, Mark Nosiglia, Mark Palmquist
-
Patent number: 12238126Abstract: Systems and methods are disclosed for improving on-chip security, while minimizes the latency and cost of security techniques to improve system-level performance and power simultaneously. The framework uses machine learning algorithms, such as an artificial neural network (ANN), for runtime attack detection with higher accuracy. Further, a learning-based attack mitigation method using deep reinforcement learning is disclosed, where the method may be used to isolate the malicious components and to optimize network latency and energy-efficiency.Type: GrantFiled: May 4, 2021Date of Patent: February 25, 2025Assignee: The George Washington UniversityInventors: Ke Wang, Hao Zheng, Ahmed Louri
-
Patent number: 12235948Abstract: A one-time self-powered timer circuit whose state can be measured only once, after which the timer will desynchronize itself. In this manner, the timers can only be used for one-pad authentication. The security of the public-key distribution algorithms that will exploit the synchronization between billions of hardware-software timers, time reversibility of software timer and time irreversibility of hardware timers and one-time read-out to deliver classical and quantum-like benefits. System-on-chip and circuit implementation of the self-powered timer array, read-out, programming and initialization modules that implements the proposed public-key distribution algorithms.Type: GrantFiled: November 6, 2020Date of Patent: February 25, 2025Assignee: Washington UniversityInventors: Shantanu Chakrabartty, Mustafizur Rahman
-
Patent number: 12235004Abstract: Systems and methods are disclosed for air flow optimization. In certain embodiments, the technology is a system comprising sensors, injectors, actuators, and a system processor. In order to optimize the air flow, the system processor directs the injectors to expel aerosol particles into an environment, such that the aerosol particles can be measured by the one or more sensors. Flow intensity map generation is then used to map the aerosol particles and air flow is changed to optimize aerosol particle concentration using the actuators.Type: GrantFiled: July 30, 2021Date of Patent: February 25, 2025Assignee: The George Washington UniversityInventors: Mark Reeves, Rahul Simha, Chen Zeng, Ali Eskandarian
-
Publication number: 20250060368Abstract: Among the various aspects of the present disclosure is the provision of methods of detecting and treating immunotherapy-resistant B cell malignancies. Methods of detection include detecting a glycosylation state of CD19 or detecting expression or activity of SPPL3 in malignant B cells, comparing to a reference state or value, and determining that the B cell malignancy is resistant to immunotherapy if the glycosylation state of CD19 or expression or activity of SPPL3 is substantially increased or decreased relative to corresponding reference levels. Also provided are therapeutic agents capable of modulating CD19 glycosylation or SPPL3 expression or activity for treatment of B cell malignancies in combination with CD19-targeted immunotherapies.Type: ApplicationFiled: February 7, 2023Publication date: February 20, 2025Applicants: Washington University, The Trustees of the University of Pennsylvania, University of AugsburgInventors: Nathan Singh, Armin Ghobadi, Marco Ruella, Saar Gill, Regina Fluhrer
-
Publication number: 20250060369Abstract: The present disclosure provides methods to quantify VCP phosphorylation at specific amino acid residue to predict responsiveness of a subject having a cancer or tumor to a genotoxic treatment, guide treatment decisions, select subjects for clinical trials, and evaluate the clinical efficacy of certain therapeutic interventions.Type: ApplicationFiled: November 5, 2024Publication date: February 20, 2025Applicant: Washington UniversityInventors: Jieya Shao, Marc Diamond
-
Patent number: 12226382Abstract: Among the various aspects of the present disclosure is the provision of methods of treating a microglial dysfunction-associated diseases, disorder, and conditions. The present disclosure provides for a method for treating microglial dysfunction in a subject having a microglial dysfunction-associated neurodegenerative disease comprising administering to a subject a therapeutically effective amount of a microglial rescuing agent. The present disclosure also provides for a method of reversing neuronal damage in a subject having a microglial dysfunction-associated neurodegenerative disease, wherein the microglial dysfunction-associated neurodegenerative disease is characterized by a single nucleotide polymorphisms (SNPs) or mutation in Trem2 or ApoE affecting microglial functions.Type: GrantFiled: August 5, 2021Date of Patent: February 18, 2025Assignee: Washington UniversityInventors: Marco Colonna, Tyler Ulland
-
Patent number: 12226575Abstract: Devices, systems, and methods of facilitating airway management with reduced risk of release of droplets and aerosolized pathogens from the lungs of a patient are disclosed, including a bronchoscope adapter for an endotracheal tube, an endotracheal tube with integral bronchoscope adapter, an endotracheal intubation mask system, a laryngeal mask airway-specific mask system, and a quick-seal laryngeal mask airway-specific mask system.Type: GrantFiled: August 9, 2021Date of Patent: February 18, 2025Assignee: Washington UniversityInventors: Mohamed Zayed, Zahid Iqbal, Jin Vivian Lee
-
Publication number: 20250049833Abstract: Disclosed are methods and compositions related to methods of treating, ameliorating, mitigating, slowing, arresting, preventing or reversing various diseases and conditions, including age-related obesity, age-related increases in blood lipid levels, age-related decreases in insulin sensitivity, age-related decreases in memory function, and age-related changes in eye function such as macular degeneration. The methods comprise administering nicotinamide mononucleotide (NMN) to a subject. In some embodiments, the administration can be oral administration. Also disclosed are pharmaceutical compositions comprising NMN.Type: ApplicationFiled: October 28, 2024Publication date: February 13, 2025Applicant: Washington UniversityInventors: Shin-ichiro Imai, Rajendra Apte
-
Patent number: 12220465Abstract: Among the various aspects of the present disclosure is the provision of compositions and methods for targeted treatment and imaging of cancers or tumors.Type: GrantFiled: November 27, 2019Date of Patent: February 11, 2025Assignee: Washington UniversityInventors: Abdel Kareem Azab, Barbara Muz
-
Patent number: 12222101Abstract: A modular combustion system for flexible energy generation is provided. The system comprises a plurality of combustion boilers, at least one oxidizer supply unit providing an oxidizer stream to the combustion boilers, at least one feeder to provide fuel to the combustion boilers, at least one particle removal unit to remove particles from a flue gas output stream from the combustion boilers, and a pollution removal unit to remove pollutant gases from the flue gas output stream. A process for flexible energy generation using the modular combustion system is disclosed that includes providing an oxidizer stream to a plurality of combustion boilers with at least one oxidizer supply unit, providing fuel to the plurality of combustion boilers with at least one feeder, removing particles from a flue gas output stream from the plurality of combustion boilers with at least one particle removal unit, and removing pollutant gases from a particle-free flue gas output stream with at least one pollution removal unit.Type: GrantFiled: July 24, 2020Date of Patent: February 11, 2025Assignee: Washington UniversityInventors: Richard Axelbaum, Zhiwei Yang, Piyush Verma
-
Patent number: 12213997Abstract: Among the various aspects of the present disclosure is the provision of compositions and methods for the generation of a supporting matrix for cells, such as stem cells and NP cells (and precursors thereof). For example, an NP cell-specific phenotype precursor cell can be an adult NP cell, such as a cell taken from the adult and degenerated intervertebral disc and/or a progenitor cell, such as stem cells, induced pluripotent cells, pluripotent cells, precursor cells, or stromal cells.Type: GrantFiled: February 2, 2021Date of Patent: February 4, 2025Assignee: Washington UniversityInventors: Lori Setton, Marcos Barcellona, Julie Speer
-
Patent number: 12215386Abstract: The invention relates to methods and kits for diagnosing and/or treating appendicitis in a subject, comprising obtaining a biological sample rom said subject; detecting RNA expression levels of at least three or more biomarkers in the biological sample and comparing the expression levels of said at least three or more biomarkers to a control sample wherein an increase or decrease in the level of expression of said at least three or more biomarkers as compared to the control sample is indicative of appendicitis.Type: GrantFiled: June 9, 2021Date of Patent: February 4, 2025Assignee: The George Washington UniversityInventors: Lakhmir S. Chawla, Timothy A. McCaffrey
-
Publication number: 20250037884Abstract: A cyber-physical system for conducting a telehealth session. In embodiments, the system includes a hardware control box that enables patients (e.g., elderly or cognitively-impaired patients) to easily participate in the telehealth session. In some embodiments, the system analyzes sensor data (e.g., thermal images, eye tracking data, etc.) and calculates state variables that form a mathematical representation (a “digital twin”) indicative of the physical, emotive, cognitive, or social state of the patient. In some of those embodiments, the system calculates Myasthenia Gravis core examination metrics by performing computer vision analysis on patient video data and/or audio analysis on patient audio data. In some embodiments, the system controls a pan-tile-zoom camera to zoom in on each region of interest that is relevant to the examination.Type: ApplicationFiled: July 31, 2024Publication date: January 30, 2025Applicants: THE GEORGE WASHINGTON UNIVERSITY, Care Constitution Corp.Inventors: Marc P. GARBEY, Guillaume JOERGER
-
Patent number: 12209023Abstract: The present disclosure relates to an improved process for the synthesis of hydrogen terminated silicon from Zintl phases. The hydrogen terminated silicon is useful, for example, as explosives, chemical and biochemical sensors, optoelectronic materials and Li-ion battery anode ion storage materials. The present disclosure also relates to an improved process for the synthesis of nanomaterials and composites from Zintl phases. The nanomaterials and composites are useful, for example, as ion storage materials.Type: GrantFiled: September 9, 2021Date of Patent: January 28, 2025Assignee: The George Washington UniversityInventors: Michael J. Wagner, Nathan A. Banek